Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Hubei Province Key Laboratory of Molecular Imaging, Wuhan 430022, China.
Theranostics. 2020 May 15;10(14):6113-6121. doi: 10.7150/thno.46569. eCollection 2020.
: To retrospectively analyze serial chest CT and clinical features in patients with coronavirus disease 2019 (COVID-19) for the assessment of temporal changes and to investigate how the changes differ in survivors and nonsurvivors. : The consecutive records of 93 patients with confirmed COVID-19 who were admitted to Wuhan Union Hospital from January 10, 2020, to February 22, 2020, were retrospectively reviewed. A series of chest CT findings and clinical data were collected and analyzed. The serial chest CT scans were scored on a semiquantitative basis according to the extent of pulmonary abnormalities. Chest CT scores in different periods (0 - 5 days, 6 - 10 days, 11 - 15 days, 16 - 20 days, and > 20 days) since symptom onset were compared between survivors and nonsurvivors, and the temporal trend of the radiographic-clinical features was analyzed. : The final cohort consisted of 93 patients: 68 survivors and 25 nonsurvivors. Nonsurvivors were significantly older than survivors. For both survivors and nonsurvivors, the chest CT scores were not different in the first period (0 - 5 days) but diverged afterwards. The mortality rate of COVID-19 monotonously increased with chest CT scores, which positively correlated with the neutrophil-to-lymphocyte ratio, neutrophil percentage, D-dimer level, lactate dehydrogenase level and erythrocyte sedimentation rate, while negatively correlated with the lymphocyte percentage and lymphocyte count. : Chest CT scores correlate well with risk factors for mortality over periods, thus they may be used as a prognostic indicator in COVID-19. While higher chest CT scores are associated with a higher mortality rate, CT images taken at least 6 days since symptom onset may contain more prognostic information than images taken at an earlier period.
回顾性分析 2019 年冠状病毒病(COVID-19)患者的系列胸部 CT 和临床特征,评估时间变化,并探讨幸存者和非幸存者之间变化的差异。
回顾性分析 2020 年 1 月 10 日至 2 月 22 日期间入住武汉协和医院的 93 例确诊 COVID-19 患者的连续记录。收集并分析了一系列胸部 CT 发现和临床数据。根据肺部异常程度,对系列胸部 CT 扫描进行半定量评分。比较不同时期(症状出现后 0-5 天、6-10 天、11-15 天、16-20 天和>20 天)幸存者和非幸存者之间的胸部 CT 评分,并分析影像学-临床特征的时间趋势。
最终队列包括 93 例患者:68 例幸存者和 25 例非幸存者。非幸存者明显比幸存者年龄大。对于幸存者和非幸存者,胸部 CT 评分在第一个时期(0-5 天)没有差异,但随后出现差异。COVID-19 的死亡率随着胸部 CT 评分的增加而单调增加,与中性粒细胞与淋巴细胞比值、中性粒细胞百分比、D-二聚体水平、乳酸脱氢酶水平和红细胞沉降率呈正相关,与淋巴细胞百分比和淋巴细胞计数呈负相关。
胸部 CT 评分与死亡率的危险因素在一段时间内密切相关,因此可作为 COVID-19 的预后指标。虽然较高的胸部 CT 评分与较高的死亡率相关,但症状出现后至少 6 天拍摄的 CT 图像可能比早期图像包含更多的预后信息。